Incyte Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, and Happy New Year. Welcome to the 39th Annual, and first and hopefully only time, Virtual JPMorgan Healthcare Conference. My name is Cory Kasimov. I'm the senior large-cap biotech analyst. And it's my pleasure to introduce Hervé Hoppenot, the Chairman and CEO of Incyte, our first company presenting today.
Please note that following Hervé's presentation, we will have a Q&A session right here in the same Zoom room. (Operator Instructions)
And so with that, let me turn things over to Hervé.
Thank you. Thank you, Cory. Welcome to this presentation, to everybody. Happy to speak about where we are at Incyte from -- here from Wilmington in Delaware. So I will be -- first, I need to say that I will be making forward-looking statement in the presentation, and I urge you to refer to the SEC document on our website.
So we are on Slide 3, and I will be using
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |